Area of research
Rheumatology · Immunology
Research interest
Research interests include Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis, and Spine and Intervertebral Disc Pathology.
Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years
Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis
OP0175 ESTABLISHING DEFINITIONS FOR DIFFICULT-TO-TREAT PSORIATIC ARTHRITIS (D2T-PsA) AND COMPLEX-TO-MANAGE PSORIATIC ARTHRITIS (C2M-PsA): INSIGHTS FROM THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) INITIATIVE
AI for imaging evaluation in rheumatology: applications of radiomics and computer vision—current status, future prospects and potential challenges
Unraveling the Challenges of Difficult-to-Treat Spondyloarthritis: SPARTAN 2024 Annual Meeting Proceedings
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis
Frequency of difficult-to-manage and treatment-refractory axial SpA: insights from the German RABBIT-SpA register using recent ASAS definitions
Machine learning <i>vs</i> human experts: sacroiliitis analysis from the RAPID-axSpA and C-OPTIMISE phase 3 axSpA trials
Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations
The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis
Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease
New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT
Dual-Energy-CT for Osteitis and Fat Lesions in Axial Spondyloarthritis: How Feasible Is Low-Dose Scanning?
Beyond the horizon: Innovations and future directions in axial-spondyloarthritis
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis
Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis
Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn's disease: Clinical and MRI results from a prospective inception cohort
Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a <scp>Time‐Shifted</scp> Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: <scp>10‐Year</scp> Results From the German Spondyloarthritis Inception Cohort